NIH-funded research R01 grant

Understanding how aging affects myelin and oligodendrocytes in Alzheimer's disease

Official title: Understanding Oligodendrocyte Lineage Dyshomeostasis during Aging and Alzheimer's Disease

Funded at University of Virginia · NIH-11447693 · Data updated 2026-11-12

This project studies how aging changes brain cells called oligodendrocytes and myelin to better understand and treat Alzheimer's-related cognitive decline.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startAugust 15, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$583,815
NIH project number1R01AG096593-01A1
Project IDNIH-11447693 on NIH RePORTER

Who could benefit from this research

Could help

Adults with aging-related cognitive concerns or early Alzheimer’s disease, and individuals able to contribute patient-related data or samples.

Less likely to help

The study is focused on mechanisms and may not directly benefit all participants; some may not experience personal improvements during the research period.

What this research studies

As people age, changes in myelin and the cells that create it may contribute to Alzheimer's disease. The study investigates how aging impacts oligodendrocyte precursor cells and myelin maintenance in the brain, using human-relevant models and possibly patient-derived data. By exploring these mechanisms, the research aims to identify new therapeutic strategies to slow or prevent Alzheimer’s-related cognitive impairment. The work involves advanced imaging and analyses to connect aging biology with AD pathology and potential treatments.

Why it matters

Potential benefit: If successful, this research could lead to new approaches to preserve myelin and cognitive function in aging and Alzheimer's disease.

How similar studies have gone: Previous work has linked myelin loss and oligodendrocyte dysfunction to aging and AD, with growing evidence supporting targeting myelin biology as a therapeutic avenue.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Lu, Tsai-Yi — University of Virginia
  • Study coordinator: Lu, Tsai-Yi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.